University Hospitals Seidman Cancer Center Treats its First Glioblastoma Patient with Duke-Originated Genetically Modified Polio Virus

University Hospitals Seidman Cancer Center Treats its First Glioblastoma Patient with Duke-Originated Genetically Modified Polio Virus

University Hospitals Seidman Cancer Center (UH) treated its first patient in a new clinical trial to validate groundbreaking effects of poliovirus on glioblastoma (GBM), a deadly Grade IV cancer of the brain. UH was the only Midwest site that participated in this...

Pin It on Pinterest